Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
In accordance with the memorandum of January 20, 2025, from the President, entitled "Regulatory Freeze Pending Review," the effective date of the final rule, entitled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use," (ACNU) is delayed until March 21, 2025.
Published
Jan 27, 2025
Effective
Mar 21, 2025
Citation
90 FR 8173
Agencies
2
Full text not available in our database.
View on Federal Register →Get a plain-English explanation of what this regulation does, which agencies are responsible, and how it affects existing rules.
No document text available yet
Docket No. FDA-2021-N-0862
0910-AH62
21 CFR 201
21 CFR 314